Skip to main content
. 2019 May 30;123(2):e350–e358. doi: 10.1016/j.bja.2019.04.054

Table 1.

Subject characteristics, primary outcome, and secondary outcomes. NRS, numeric rating pain scores; ns, not significant

Intervention (n=25) Control (n=26) P-value
Patient characteristics
 Sex (female/male) 12/13 14/12
 Age (yr), mean (range) 58.5 (29–82) 61.7 (34–83)
 BMI (kg m−2) 26.4 (4.2) 26.6 (5.9)
 Weight (kg) 78.4 81.2
 ASA score physical status 1/2/3 5/15/5 5/17/4
 Surgery time (min) 97.6 (25.0) 101.1 (34.3)
 Nephrostomy (n) 18 20
 Time to removal of nephrostomy (days) 1.2 (0.5) 1.3 (0.7)
Primary outcome
 Oral morphine equivalents 0–6 h (mg) 7.2 (8.7) 90.6 (69.9) <0.001
Secondary outcomes
 Oral morphine equivalents 6–12 h (mg) 5.4 (9.6) 14.42 (13.74) <0.009*
 Oral morphine equivalents 12–18 h (mg) 16.8 (11.72) 10.38 (10.19) 0.04*
 Oral morphine equivalents 18–24 h (mg) 24.6 (20.71) 10.38 (9.27) <0.004*
 Total oral morphine equivalents 0–24 h (mg) 54.0 (36.74) 126.15 (85.53) <0.0011*
 Time to removal of nephrostomy (days) 1.2 (0.5) 1.3 (0.7) ns
 Length of stay (days) 2.0 (0.78) 3.03 (1.25) <0.001
 Time to first opioid (min) 678.0 (285.0–1025.0) 36 (19.0–55) <0.0001
 Nausea/vomiting (n) 4/0 7/0 ns
 NRS score (0–10/10), block procedural pain (0–10/10) 1.36 (1.2) 1.85 (1.35) <0.2

∗ When adjusting the P-value with a factor 4 because of repeated measures (Bonferroni correction) in the 6 h intervals, differences between the groups remained statistically significant.